Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 222

1.

Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation.

Schnabel RB, Pecen L, Ojeda FM, Lucerna M, Rzayeva N, Blankenberg S, Darius H, Kotecha D, Caterina R, Kirchhof P.

Heart. 2017 Feb 22. pii: heartjnl-2016-310406. doi: 10.1136/heartjnl-2016-310406. [Epub ahead of print]

PMID:
28228467
2.

Characterization and referral patterns of ST-elevation myocardial infarction patients admitted to chest pain units rather than directly to catherization laboratories. Data from the German Chest Pain Unit Registry.

Schmidt FP, Perne A, Hochadel M, Giannitsis E, Darius H, Maier LS, Schmitt C, Heusch G, Voigtländer T, Mudra H, Gori T, Senges J, Münzel T; German Chest Pain Unit Registry..

Int J Cardiol. 2017 Mar 15;231:31-35. doi: 10.1016/j.ijcard.2016.12.017.

PMID:
28189192
3.

[NOAC: Real-life data and the role of antidotes for the treatment of bleeding].

Darius H.

Med Klin Intensivmed Notfmed. 2017 Jan 31. doi: 10.1007/s00063-016-0258-5. [Epub ahead of print] German.

PMID:
28144725
4.

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.

Haas S, Ten Cate H, Accetta G, Angchaisuksiri P, Bassand JP, Camm AJ, Corbalan R, Darius H, Fitzmaurice DA, Goldhaber SZ, Goto S, Jacobson B, Kayani G, Mantovani LG, Misselwitz F, Pieper K, Schellong SM, Stepinska J, Turpie AG, van Eickels M, Kakkar AK; GARFIELD-AF Investigators..

PLoS One. 2016 Oct 28;11(10):e0164076. doi: 10.1371/journal.pone.0164076.

5.

[Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation].

Helms TM, Silber S, Schäfer A, Masuhr F, Palm F, Darius H, Schrör K, Bänsch D, Bramlage P, Hankowitz J, Karle CA, Stargardt T, Weil J, Geller JC.

Herzschrittmacherther Elektrophysiol. 2016 Sep;27(3):295-306. doi: 10.1007/s00399-016-0447-1. German.

PMID:
27576696
6.

[Bleeding in patients receiving dual antiplatelet therapy after acute coronary syndrome - significance, prevention and interdisciplinary management].

Zeymer U, Koscielny J, von Heymann C, Spannagl M, Labenz J, Cremer J, Giannitsis E, Darius H, Goss F.

Dtsch Med Wochenschr. 2016 Jul;141(15):1107-11. doi: 10.1055/s-0042-106944. German.

PMID:
27464285
7.

Fluorescent Receptor Binding Assay for Detecting Ciguatoxins in Fish.

Hardison DR, Holland WC, McCall JR, Bourdelais AJ, Baden DG, Darius HT, Chinain M, Tester PA, Shea D, Quintana HA, Morris JA Jr, Litaker RW.

PLoS One. 2016 Apr 13;11(4):e0153348. doi: 10.1371/journal.pone.0153348.

8.

[Anticoagulant activity is rapidly reversed].

Darius H.

MMW Fortschr Med. 2016 Feb 4;158(2):67. German. No abstract available.

PMID:
27017636
9.

Erratum to: Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2015.

Post F, Gori T, Giannitsis E, Darius H, Baldus S, Hamm C, Hambrecht R, Hofmeister HM, Katus H, Perings S, Senges J, Münzel T.

Clin Res Cardiol. 2016 Apr;105(4):376. doi: 10.1007/s00392-016-0960-6. No abstract available.

10.

[Risk-adapted anticoagulation in atrial fibrillation in Germany, Austria and Switzerland - an analysis from the PREFER-in-AF study].

Steffel J, Gwechenberger M, Müller MW, Ammentorp B, Darius H, Kirchhof P.

Dtsch Med Wochenschr. 2015 Nov;140(23):e247-55. doi: 10.1055/s-0041-108996. German.

PMID:
26583826
11.

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.

Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; DAPT Study Investigators..

JACC Cardiovasc Interv. 2015 Oct;8(12):1552-62. doi: 10.1016/j.jcin.2015.05.026. Erratum in: JACC Cardiovasc Interv. 2015 Dec 21;8(14):1913.

12.

Admission heart rate in relation to presentation and prognosis in patients with acute myocardial infarction. Treatment regimens in German chest pain units.

Perne A, Schmidt FP, Hochadel M, Giannitsis E, Darius H, Maier LS, Schmitt C, Heusch G, Voigtländer T, Mudra H, Gori T, Senges J, Münzel T; German Chest Pain Unit Registry..

Herz. 2016 May;41(3):233-40. doi: 10.1007/s00059-015-4355-7.

PMID:
26411426
13.

Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2014.

Post F, Gori T, Giannitsis E, Darius H, Baldus S, Hamm C, Hambrecht R, Hofmeister HM, Katus H, Perings S, Senges J, Münzel T.

Clin Res Cardiol. 2015 Nov;104(11):918-28. doi: 10.1007/s00392-015-0888-2. Review. Erratum in: Clin Res Cardiol. 2016 Apr;105(4):376.

14.

Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial.

Brambatti M, Darius H, Oldgren J, Clemens A, Noack HH, Brueckmann M, Yusuf S, Wallentin L, Ezekowitz MD, Connolly SJ, Healey JS.

Int J Cardiol. 2015 Oct 1;196:127-31. doi: 10.1016/j.ijcard.2015.05.141.

PMID:
26093161
15.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators..

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489.

16.

Use and impact of thrombectomy in primary percutaneous coronary intervention for acute myocardial infarction with persistent ST-segment elevation: results of the prospective ALKK PCI-registry.

Härle T, Zeymer U, Hochadel M, Schmidt K, Zahn R, Darius H, Behrens S, Lauer B, Mudra H, Schächinger V, Elsässer A.

Clin Res Cardiol. 2015 Oct;104(10):803-11. doi: 10.1007/s00392-015-0846-z.

PMID:
25805412
17.

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; Dual Antiplatelet Therapy (DAPT) Study Investigators..

JAMA. 2015 Mar 17;313(11):1113-21. doi: 10.1001/jama.2015.1671. Erratum in: JAMA. 2016 Jul 5;316(1):105. JAMA. 2016 Jul 5;316(1):105. JAMA. 2015 Jun 2;313(21):2185.

18.

Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.

De Ferrari GM, Maier LS, Mont L, Schwartz PJ, Simonis G, Leschke M, Gronda E, Boriani G, Darius H, Guillamón Torán L, Savelieva I, Dusi V, Marchionni N, Quintana Rendón M, Schumacher K, Tonini G, Melani L, Giannelli S, Alberto Maggi C, Camm AJ; RAFFAELLO Investigators (see Online Supplementary Appendix for List of Participating Centers and Investigators)..

Heart Rhythm. 2015 May;12(5):872-8. doi: 10.1016/j.hrthm.2015.01.021.

PMID:
25602175
19.

The German CPU Registry: Dyspnea independently predicts negative short-term outcome in patients admitted to German Chest Pain Units.

Hellenkamp K, Darius H, Giannitsis E, Erbel R, Haude M, Hamm C, Hasenfuss G, Heusch G, Mudra H, Münzel T, Schmitt C, Schumacher B, Senges J, Voigtländer T, Maier LS.

Int J Cardiol. 2015 Feb 15;181:88-95. doi: 10.1016/j.ijcard.2014.11.199.

PMID:
25497526
20.

Guideline-adherence and perspectives in the acute management of unstable angina - Initial results from the German chest pain unit registry.

Breuckmann F, Hochadel M, Darius H, Giannitsis E, Münzel T, Maier LS, Schmitt C, Schumacher B, Heusch G, Voigtländer T, Mudra H, Senges J.

J Cardiol. 2015 Aug;66(2):108-13. doi: 10.1016/j.jjcc.2014.11.003.

Items per page

Supplemental Content

Loading ...
Support Center